Genelabs Technologies

Genelabs Technologies

Genelabs Technologies is a biopharmaceutical company developing treatments for infectious disease.

No article has been written about this topic yet.
Paste a URL about this topic to auto-extract knowledge.
Visit our Writing Guide for help on how to write about a topic,
and check out an example of a well filled out topic page.

No article has been written about this topic yet.
Be the first one to add some text.

Loading AI-assisted edit mode...

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Genelabs Technologies funding round, June 2006
8,300,000
June 27, 2006
1 Result
Results per page:
Page 1 of 1

People

Name
Role
LinkedIn

Brian Frenzel

Employee

Daniel Clinton Webb

Employee

Daniel Webb

Employee

Steven Hochhauser

Employee

Thomas W. Bruice, M.D., Ph.D.

Employee

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.